Vanguard Group Portfolio holdings
Vanguard Group is an investment manager owned by the funds it manages, and so by its own customers. John Bogle founded it in 1975 and is credited with creating the first index fund available to individual investors. After Wellington Management fired Bogle in 1974, he started a new fund division there and named it Vanguard after HMS Vanguard, Horatio Nelson's flagship. Bogle set up its first index fund in 1976, the fund that became the Vanguard 500 Index Fund, and the firm added a bond index fund in 1986. It began offering ETFs in 2001 as exchange-traded shares of its index funds, and it also serves employers' retirement plans and independent financial advisers. Salim Ramji, who came from BlackRock, was named chief executive in 2024 as the first outsider to lead the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.03B |
| 2 |
Microsoft
MSFT
|
+$8B |
| 3 |
Apple
AAPL
|
+$7.21B |
| 4 |
TotalEnergies
TTE
|
+$5.18B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.85B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$2.74B |
| 2 |
DuPont de Nemours
DD
|
+$2.65B |
| 3 |
Mr. Cooper
COOP
|
+$1.41B |
| 4 |
Interpublic Group of Companies
IPG
|
+$1.24B |
| 5 |
Amazon
AMZN
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 9.9% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3701
Safe Pro Group Inc
SPAI
$58.1M
| $1.33M | ﹤0.01% |
318,680
+157,766
| +98% | +$867K |
2025 Q3
1 quarter
|
|
3702
Clene
CLNN
$56.4M
| $1.31M | ﹤0.01% |
222,909
+21,930
| +11% | +$182K |
2021 Q1
19 quarters
|
|
3703
Biodesix
BDSX
$110M
| $1.31M | ﹤0.01% |
192,138
+10,234
| +6% | +$75.4K |
2020 Q4
20 quarters
|
|
3704
DELISTED
Generation Bio
GBIO
| $1.31M | ﹤0.01% |
229,833
| – | – |
2020 Q2
22 quarters
|
|
3705
NextCure
NXTC
$29.3M
| $1.3M | ﹤0.01% |
91,910
+23,927
| +35% | +$248K |
2019 Q2
26 quarters
|
|
3706
Schwab International Dividend Equity ETF
SCHY
$2.74B
| $1.3M | ﹤0.01% |
43,724
+18
| +0% | +$520 |
2023 Q3
9 quarters
|
|
3707
XBP Global Holdings
XBP
$42.5M
| $1.29M | ﹤0.01% |
189,521
-1
| -0% | -$6 |
2024 Q1
7 quarters
|
|
3708
Harvard Bioscience
HBIO
$42.9M
| $1.29M | ﹤0.01% |
192,328
+7,143
| +4% | +$42.4K |
2013 Q2
50 quarters
|
|
3709
Torrid Holdings
CURV
$226M
| $1.28M | ﹤0.01% |
1,306,936
-3,762
| -0.3% | -$4.81K |
2021 Q3
17 quarters
|
|
3710
MarketWise
MKTW
$55.4M
| $1.27M | ﹤0.01% |
84,595
+968
| +1% | +$15.1K |
2021 Q3
17 quarters
|
|
3711
Almonty Industries
ALM
$2.37B
| $1.27M | ﹤0.01% |
+144,168
| New | +$1.06M |
2025 Q4
0 quarters
|
|
3712
iShares S&P 500 Value ETF
IVE
$51.6B
| $1.26M | ﹤0.01% |
5,949
+52
| +0.9% | +$10.9K |
2023 Q2
10 quarters
|
|
3713
Vanguard Real Estate ETF
VNQ
$38.6B
| $1.24M | ﹤0.01% |
14,060
-3,611
| -20% | -$325K |
2023 Q1
11 quarters
|
|
3714
BeyondSpring
BYSI
$24.7M
| $1.24M | ﹤0.01% |
758,953
+212,254
| +39% | +$408K |
2025 Q2
2 quarters
|
|
3715
AN2 Therapeutics
ANTX
$173M
| $1.23M | ﹤0.01% |
1,080,070
| – | – |
2022 Q1
15 quarters
|
|
3716
Mastech Digital
MHH
$75.4M
| $1.22M | ﹤0.01% |
175,312
+5,187
| +3% | +$37.3K |
2013 Q2
50 quarters
|
|
3717
Ispire Technology
ISPR
$97.6M
| $1.21M | ﹤0.01% |
433,403
+11,879
| +3% | +$27.6K |
2023 Q2
10 quarters
|
|
3718
Drilling Tools International
DTI
$63.2M
| $1.21M | ﹤0.01% |
494,900
+40,519
| +9% | +$97.5K |
2023 Q4
8 quarters
|
|
3719
LASE Corp. Common Stock
LASE
$31.9M
| $1.21M | ﹤0.01% |
489,378
+156,031
| +47% | +$524K |
2023 Q1
11 quarters
|
|
3720
VistaGen Therapeutics
VTGN
$8.01M
| $1.21M | ﹤0.01% |
1,824,738
+137,003
| +8% | +$495K |
2018 Q1
31 quarters
|
|
3721
MediWound
MDWD
$186M
| $1.21M | ﹤0.01% |
65,296
+14,198
| +28% | +$259K |
2024 Q2
6 quarters
|
|
3722
KLX Energy Services
KLXE
$135M
| $1.2M | ﹤0.01% |
635,347
-11,351
| -2% | -$19.8K |
2018 Q3
29 quarters
|
|
3723
DELISTED
Origin Materials
ORGN
| $1.2M | ﹤0.01% |
188,231
+3,136
| +2% | +$45.8K |
2021 Q3
17 quarters
|
|
3724
NeuroOne Medical Technologies
NMTC
$6.78M
| $1.2M | ﹤0.01% |
263,040
| – | – |
2021 Q4
16 quarters
|
|
3725
Spectral AI
MDAI
$41.8M
| $1.2M | ﹤0.01% |
842,049
+228,777
| +37% | +$425K |
2024 Q1
7 quarters
|
|
Similar funds
Vanguard Group's Q4 2025 Portfolio in Review
As of Q4 2025, Vanguard Group held 4,426 positions worth $6.9T, up 3.3% from $6.68T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.1%. Vanguard Group opened 82 new positions and exited 98, leaving the 4,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2025 buy was TotalEnergies: 81,863,403 shares worth $5.34B.
- Vanguard Group added most to NVIDIA in Q4 2025, an estimated $8.03B increase.
- Vanguard Group's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $2.65B.
- Vanguard Group fully exited Kellanova in Q4 2025, selling an estimated $2.74B.
- Vanguard Group's ten largest holdings make up 31% of its $6.9T portfolio in Q4 2025.
- Vanguard Group opened 82 new positions and closed 98 in Q4 2025.
- Vanguard Group's portfolio value rose 3.3% quarter-over-quarter to $6.9T.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.